We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Distribution Agreement

10 Apr 2013 07:00

RNS Number : 9680B
Omega Diagnostics Group PLC
09 April 2013
 



 

Omega Diagnostics Group PLC

("Omega" or the "Company")

 

Distributor Agreement

 

10 April 2013

 

 

Omega (AIM:ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, is pleased to announce it has agreed to amend the Terms of its existing licence agreement with Immunodiagnostic Systems Holdings plc (IDS) allowing the Company to appoint IDS as its exclusive distributor in certain territories for allergy tests to be run on the automated IDS-iSYS platform. The countries covered by the agreement are those countries where IDS already has a direct presence, namely, the USA, Germany, France, the Nordic regions and the UK.

 

It is envisaged that the Company and IDS will enter into a distribution agreement in due course which will provide IDS customers with an increased menu of tests on the IDS-iSYS platform and will allow Omega to reduce its time to market in the selected countries. The Company is still developing an initial launch panel of 40+ allergy tests with a planned launch date in the final quarter of the new financial year ending 31 March 2014.

 

 

 

 

Contacts:

 

Omega Diagnostics Group PLC Tel: 01259 763 030

Andrew Shepherd, Chief Executive www.omegadiagnostics.com

Kieron Harbinson, Group Finance Director

Jag Grewal, Group Sales and Marketing Director

finnCap Ltd Tel: 020 7220 0500

Geoff Nash/Christopher Raggett (Corporate Finance)

Stephen Norcross/Mia Gardner (Corporate Broking)

Walbrook PR Limited Tel: 020 7933 8780

Paul McManus Mob: 07980 541 893; paul.mcmanus@wallbrookpr.com

Lianne Cawthorne Mob: 07584 391 303; lianne.cawthorne@walbrookpr.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRNKCDBBBKBCQK
Date   Source Headline
6th Sep 20237:00 amRNSAGM Statement
1st Sep 202310:29 amRNSUpdate on proposed Share Reorganisation
31st Aug 20237:00 amRNSProposed Share Reorganisation Timetable
22nd Aug 20237:00 amRNSDirectorate Change
17th Aug 20237:00 amRNSBoard Appointment
15th Aug 20231:45 pmRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSPosting of Annual Report and confirmation of AGM
3rd Aug 20237:00 amRNSFinal Results
27th Jul 20237:00 amRNSNotice of Results
26th Jul 20232:10 pmRNSHolding(s) in Company
6th Jun 202311:19 amRNSHolding(s) in Company
5th Jun 20234:51 pmRNSHolding(s) in Company
2nd Jun 20232:45 pmRNSHolding(s) in Company
22nd May 20235:33 pmRNSHolding(s) in Company
10th May 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th May 20233:42 pmRNSDirector/PDMR Shareholding
21st Apr 20239:48 amRNSHolding(s) in Company
19th Apr 20239:31 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update
22nd Mar 20235:57 pmRNSBlock Listing Six Monthly Return
22nd Mar 20233:00 pmRNSHolding(s) in Company
6th Mar 20232:31 pmRNSHolding(s) in Company
27th Jan 20233:03 pmRNSHolding(s) in Company
27th Jan 20239:36 amRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSTrading update
16th Jan 202310:56 amRNSHolding(s) in Company
6th Jan 20237:00 amRNSUS expansion update
3rd Jan 202312:34 pmRNSHolding(s) in Company
13th Dec 20224:40 pmRNSSecond Price Monitoring Extn
13th Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 202212:01 pmRNSHolding(s) in Company
30th Nov 20229:35 amRNSHolding(s) in Company
25th Nov 20227:00 amRNSReceipt of deferred consideration
24th Nov 20227:00 amRNSHalf-year Report
23rd Nov 20224:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20222:05 pmRNSSecond Price Monitoring Extn
23rd Nov 20222:00 pmRNSPrice Monitoring Extension
18th Nov 202212:09 pmRNSHolding(s) in Company
16th Nov 20222:06 pmRNSSecond Price Monitoring Extn
16th Nov 20222:00 pmRNSPrice Monitoring Extension
15th Nov 20227:00 amRNSConfirmation of Results and Investor Presentation
14th Nov 20227:00 amRNSPartnership agreement with Software Provider
8th Nov 20229:04 amRNSLaunch of new all-employee share incentive plan
26th Oct 20222:50 pmRNSResult of AGM
26th Oct 20227:00 amRNSAGM Statement and Notice of Results
11th Oct 20227:00 amRNSScientific Director to present at FIDHC
5th Oct 20227:00 amRNSPositive WHO data received for VISITECT® CD4 test
27th Sep 20227:00 amRNSPosting of Annual Report and confirmation of AGM
20th Sep 202212:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.